Cite
HARVARD Citation
Duska, L. et al. (2016). Risk Factors for Readmission in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Who Are Receiving Front-line Chemotherapy on a Clinical Trial (GOG 218). Obstetrical & gynecological survey. 71 (1), p. . [Online].